Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.

Gilles R DagenaisLeanne DyalJacqueline J BoschDarryl P LeongVictor AboyansScott D BerkowitzDeepak L BhattStuart J ConnollyKeith A A FoxEva MuehlhoferJeffrey L ProbstfieldPetr WidimskyBernhard R WinkelmannSalim YusufJohn W Eikelboom

Published in: Heart (British Cardiac Society) (2021)

NCT01776424.

Keyphrases

peripheral artery disease
low dose
coronary artery disease
venous thromboembolism
coronary artery
atrial fibrillation
high dose
pulmonary embolism
heart failure
aortic stenosis
left ventricular
transcatheter aortic valve replacement
ejection fraction